Abstract:Advanced gallbladder cancer (GBC) is one of the most malignant of all types of biliary tract cancers that is associated with poor prognosis and high mortality. Accumulating evidence suggest that the B7 family of proteins serve an essential role in various types of cancers, including GBC. However, the potential function and regulatory mechanism of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2; also known as B7-H7 or B7H5) in GBC remain poorly understood. In the present study, immunohistochemistry was used to examine the expression pattern of HHLA2 in samples from 89 patients with GBC. The possible association between HHLA2 expression and the clinicopathological parameters, including prognosis, were then assessed. Using lentiviruses, overexpression of HHLA2 plasmid or short-hairpin RNA (shRNA) of HHLA2 were transfected into GBC-SD cells to overexpress or knock down HHLA2 expression, respectively. The effects of HHLA2 overexpression and knockdown on the epithelial-mesenchymal transition (EMT) process on GBC-SD cells were measured by the western blotting and immunofluorescence staining of collagen I, N-cadherin, E-cadherin, vimentin and α-SMA. By contrast, changes in cell proliferation were measured using EdU assay. Cell invasion and migration were assessed using Transwell and wound-healing assays, respectively. In addition, a xenograft mouse model was established to evaluate the tumorigenic ability of the GBC cell line in vivo after stable transfection with lentivirus for HHLA2 overexpression or shRNA for HHLA2 knockdown. The regulatory relationships among TGF-β1, long non-coding RNA (lncRNA) H19 (H19) and HHLA2 were then investigated. The mRNA expression of lncRNA H19 were assessed using reverse transcription-quantitative PCR, whereas the expression levels of HHLA2 were detected by western blotting and immunofluorescence staining. HHLA2 expression was found to gradually increase as the stages of the GBC samples become more advanced. In addition, the expression level of HHLA2 was calculated to be positively associated with the Nevin stage, American Joint Committee on Cancer stage, tumor invasion and regional lymph node metastasis but was negatively associated with the overall patient survival (OS). In vitro experiments demonstrated that overexpression of HHLA2 promoted GBC migration, invasion, proliferation and EMT, whereas in vivo experiments found a promoting role of HHLA2 overexpression on GBC tumor growth. After transfection with lentiviruses encoding the overexpression plasmid of lncRNA H19, GBC migration, invasion, proliferation and EMT were increased. By contrast, knocking down HHLA2 expression suppressed TGF-β1- or lncRNA H19 overexpression-induced GBC migration, invasion, proliferation and EMT. In addition, HHLA2 knockdown significantly reduced the sizes of the GBC tumors in vivo. These results suggest that HHLA2 overexpression can promote GBC progression. Conversely, ablation of HHLA2 expression inhibited both TGF-β1- and lncRNA H19-induced GBC progression, suggesting that HHLA2 is a potential therapeutic target for this disease.

B4GALNT2 Gene Promotes Proliferation, and Invasiveness and Migration Abilities of Model Triple Negative Breast Cancer (TNBC) Cells by Interacting with HLA-B Protein

HHLA2 Promotes Tumor Progression by Long Non-Coding RNA H19 in Human Gallbladder Cancer

B3GALT4 modulates tumor progression and autophagy by AKT/mTOR signaling pathway in breast cancer

BTG2 Inhibits the Proliferation, Invasion, and Apoptosis of MDA-MB-231 Triple-Negative Breast Cancer Cells

BTG2 As a Tumor Target for the Treatment of Luminal A Breast Cancer

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness

Reduced expression of ppGalNAc‐T4 promotes proliferation of human breast cancer cells

Β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells Through Wnt/β-catenin Signaling Pathway.

B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.

B4GALT3 Promotes Cell Proliferation and Invasion in Glioblastoma

Galnt6 Promotes Tumorigenicity And Metastasis Of Breast Cancer Cell Via Beta-Catenin/Muc1-C Signaling Pathway

PBX3-activated DLG1-AS1 Can Promote the Proliferation, Invasion and Migration of TNBC Cells by Sponging Mir-16-5p

Increased B3GALNT2 in Hepatocellular Carcinoma Promotes Macrophage Recruitment Via Reducing Acetoacetate Secretion and Elevating MIF Activity

HOXD Antisense Growth-Associated Long Noncoding RNA Promotes Triple-Negative Breast Cancer Progression by Activating Wnt Signaling Pathway

CCT6A and Triple-Negative Breast Cancer Metastasis: Activating the AKT/MDM2/P53 Pathway

BCL11A Confers Cell Invasion and Migration in Androgen Receptor-Positive Triple-Negative Breast Cancer

Long Non-Coding Rna Lrrc75a-As1 Facilitates Triple Negative Breast Cancer Cell Proliferation And Invasion Via Functioning As A Cerna To Modulate Baalc

Long Noncoding RNA H19 Contributes to Gallbladder Cancer Cell Proliferation by Modulated Mir-194-5p Targeting AKT2.

Knockdown of B7H6 Inhibits Tumor Progression in Triple-Negative Breast Cancer.

Ppgalnac-T4-catalyzed O-Glycosylation of TGF-β Type Ⅱ Receptor Regulates Breast Cancer Cells Metastasis Potential

Bcl-3 Promotes Proliferation and Chemosensitivity in BL1 Subtype of TNBC Cells